Patricia L. Allen
Independent DirectorMs. Patricia L. Allen, also known as Patty, CPA, serves as an Independent Director at Zenas BioPharma Inc from February 2024. serves as Director at Zenas BioPharma Limited from March 2024. She serves as Independent Director of SwanBio Therapeutics Ltd. She has been Director at Anokion SA. since September 2020. She served as Chief Financial Officer of Vividion Therapeutics Inc. since March 2021. She has been Independent Director of Yumanity Therapeutics Inc. since December 22, 2020. She previously served as a member of the board of directors of Yumanity, Inc. since August 2019. Ms. Allen has financial leadership experience in the biotechnology industry at both publicly-traded and private companies. From 2011 to 2012, she provided independent consulting services to biotechnology companies in a variety of areas, including interim CFO services, fundraising, deal structures, financial planning, organizational structure, investor relations and business development. She served as Chief Financial Officer of Zafgen, Inc. (now Larimar Therapeutics) since January 4, 2013 until May 2020. She provided independent consulting services to biotechnology companies in a variety of areas, including Interim Chief Financial Officer Services, fundraising, deal structures, financial planning, organizational structure, Investor Relations and business development since 2011 until 2012. She served as the Principal Financial Officer and Principal Accounting Officer of Alnylam Pharmaceuticals, Inc. until February 28, 2011 and its Consultant from February 28, 2011 to March 21, 2012. She served as Chief Financial Officer of Larimar Therapeutics, Inc. Ms. Allen served as a Director of Kineta, Inc. until December 2022. Ms. Allen served as Vice President of Finance at Alnylam Pharmaceuticals Inc. from June 24, 2004 to February 28, 2011 and as its Treasurer from January 1, 2006 to February 28, 2011. She was responsible for Leading and managing all aspects of Finance Activities at Alnylam. Prior to Alnylam, Ms. Allen was at Alkermes, Inc. and as the Director of Finance and Assistant Secretary. She was past board member at Inversago Pharma. Ms. Allen began her career as an Auditor at Deloitte & Touche, LLP. She was an Independent Director of Deciphera Pharmaceuticals, Inc. since September 2016 until June 11, 2024. Ms. Allen graduated summa cum laude with a B.S. in Business Administration from Bryant College and is a Certified Public Accountant.
Positions
- Company NameZenas BioPharma, Inc.Stock CodeZBIOPositionIndependent DirectorColleagues
- LOLeon Oliver MoulderFounder, CEO & Chairman
- JLJoseph L. FarmerCOO, President, Principal Financial Officer & Principal Accounting Officer
- LVLisa von MoltkeHead of Research & Development and Chief Medical Officer
- HSHeinrich SchliekerChief Technical Officer
- HLHaley LakenChief Scientific Officer
- JJJohn Jacob OrloffIndependent Director
- JRJason Raleigh NunnIndependent Director
- JPJames Patrick BoylanLead Independent Director
